Calendario de promoción Phathom Pharmaceuticals, Inc.
Horario avanzado
gráfico sencillo
Acerca de la empresa
Phathom Pharmaceuticals Inc (Phathom Pharmaceuticals) — биофармацевтическая компания, занимающаяся разработкой и коммерциализацией лекарственных средств для лечения заболеваний желудочно-кишечного тракта (ЖКТ). Компания предлагает линейку продуктов, включающую вонопразан, пероральный низкомолекулярный блокатор калия, конкурирующий с кислотой (P-CAB). Он также оценивает его вонопразан в сочетании с антибиотиками для лечения инфекции Helicobacter pylori.
Más detalles| Цена ао | 18.27 |
|---|---|
| Сайт | https://www.phathompharma.com |
| EBITDA | -0.1547 |
| EV/EBITDA | -3.59 |
| Див.доход ао | 0 |
| P/BV | 3.4 |
| ISIN | US71722W1071 |
| Число акций ао | 0.05129 млрд |
| Выручка | 0.000682 |
| P/S | 691.88 |
| Валюта | usd |
| IPO date | 2019-10-25 |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Валюта отчета | usd |
| Cambio de precio por día: | +10.13% (16.59) |
|---|---|
| Cambio de precio por semana.: | +16.3% (15.71) |
| Cambio de precio por mes: | -1.19% (18.49) |
| Cambio de precio en 3 meses.: | +63.42% (11.18) |
| Cambio de precio en seis meses: | +103.68% (8.97) |
| Cambio de precio por año: | +100.11% (9.13) |
| Cambio de precio en 3 años.: | -42.92% (32.01) |
| Cambio de precio desde principios de año.: | +148.91% (7.34) |
|
|
Subestimación
|
Eficiencia
|
|||||||||||||||||||||||||||||||||||||
Dividendos
|
Deber
|
Impulso de crecimiento
|
|||||||||||||||||||||||||||||||||||||
| Instituciones | Volumen | Compartir, % |
|---|---|---|
| Frazier Life Sciences Management, L.P. | 10109279 | 17.29 |
| Medicxi Ventures Management (Jersey) Ltd | 3760869 | 6.43 |
| Carlyle Group Inc. | 3496808 | 5.98 |
| Invesco Ltd. | 3167653 | 5.42 |
| Blackrock Inc. | 2678891 | 4.58 |
| Ensign Peak Advisors, Inc | 2280000 | 3.9 |
| NEA Management Company, LLC | 1960169 | 3.35 |
| Vanguard Group Inc | 1956429 | 3.35 |
| Avidity Partners Management, LP | 1721580 | 2.94 |
| Gilder, Gagnon, Howe & Co. | 1455132 | 2.49 |
| ETF | Compartir, % | Rentabilidad del año, % | Dividendos, % |
|---|---|---|---|
| Virtus LifeSci Biotech Products ETF | 2.47703 | 36.788704846892 | 0.13953 |
| Avantis U.S. Equity ETF | 0.00007 | 30.365392144069 | 1.59151 |
| ProShares Ultra Nasdaq Biotechnology | 0.07479 | 51.697637072723 | 0.85651 |
| iShares ESG Aware MSCI USA Small-Cap ETF | 0.0695 | 31.110458284371 | 1.49366 |
| Fidelity MSCI Health Care Index ETF | 0.0107 | 16.20294599018 | 1.46057 |
| ProShares Hedge Replication ETF | 0.00401 | 5.9237999659878 | 1.47892 |
| Humankind US Stock ETF | 0.00358 | 18.809430395549 | 1.99919 |
| Invesco Nasdaq Biotechnology ETF | 0.10564 | 28.578975171685 | 0.8565 |
| iShares U.S. Pharmaceuticals ETF | 0.25475 | 19.78048362202 | 1.97922 |
| iShares Morningstar Small-Cap ETF | 0.01336 | 30.095066471445 | 1.60498 |
| iShares Micro-Cap ETF | 0.15947 | 34.327031588619 | 1.54048 |
| iShares Russell 2000 Growth ETF | 0.01041 | 38.042556988 | 0.6026 |
| iShares Russell 3000 ETF | 0.00114 | 31.230028873917 | 1.43482 |
| iShares Morningstar Small-Cap ETF | 0.01336 | 391.25300933451 | 1.60498 |
| Nuveen ESG Small-Cap ETF | 0.07307 | 27.987510644337 | 1.41019 |
| Schwab U.S. Small-Cap ETF | 0.01735 | -34.641922436355 | 1.51433 |
| Schwab U.S. Broad Market ETF | 0.00134 | -56.193181818182 | 1.43354 |
| SPDR Portfolio MSCI Global Stock Market ETF | 0.00498 | 23.658352229781 | 2.19607 |
| ProShares UltraPro Russell2000 | 0.01357 | 89.821266282945 | 1.47873 |
| Vanguard Russell 3000 ETF | 0 | 31.87314172448 | 1.43817 |
| Vanguard Russell 2000 Growth ETF | 0.01 | 37.361289927043 | 0.60264 |
| Vanguard Russell 2000 ETF | 0.02 | 32.773459189339 | 1.48801 |
| Principal Healthcare Innovators ETF | 0.12211 | 618.4964157054 | 0.8416 |
| Future Tech ETF | 0.12211 | 426.33969118983 | 0.8416 |
| SPDR S&P Pharmaceuticals ETF | 0.95686 | 29.798803697662 | 1.29889 |
| Supervisor | Título profesional | Pago | año de nacimiento |
|---|---|---|---|
| Ms. Terrie J. Curran | President, CEO & Director | 1.11M | 1969 (55 años) |
| Mr. David A. Socks | Co-Founder & Director | 58.78k | 1975 (49 años) |
| Dr. Azmi Nabulsi M.D., M.P.H. | Co-Founder & COO | 815.21k | 1960 (64 año) |
| Ms. Molly Henderson CPA, MBA | Chief Financial & Business Officer | 671.27k | 1971 (53 año) |
| Mr. Tom Harris | Chief Development Sciences Officer | N/A | |
| Dr. Eckhard Leifke M.D., Ph.D. | Chief Medical Officer | N/A | |
| Dr. Aditya Kohli Ph.D. | Co-Founder | 319.65k | 1988 (36 años) |
| Mr. Martin J. Gilligan | Chief Commercial Officer | N/A | |
| Mr. Paul Cocja | Chief People Officer |
DIRECCIÓN: United States, Florham Park. NJ, 100 Campus Drive - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://www.phathompharma.com
Sitio web: https://www.phathompharma.com
